TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/26/2024
Back to search
Official data from USPTO
EXSCALATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/26/2024
Trademark type
Combined
Nice classes
9, 42
Filing date
11/23/2022
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
12/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
IT
Examiner
WATTS-FITZGERALD, CAITLIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "EXSCALATE" in black, to the left of which appears a red, dark red, and light red cube design outlined in black, the rear of which is a square shape while the front shape is that of an X. White indicates transparent matter and is not claimed as a feature of the mark.
Holders and representatives
Holders
Dompe' farmaceutici Spa
Representatives
Theodore R. Remaklus Thompson Hine LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturingtrackingreportinganalyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teachingspecificallyfor granting user access to courses of instruction in the medical field; downloadable virtual screening softwarespecificallysoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesfacilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models in the field of healthcare
Class 42
Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; providing temporary use of onlinenon-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine
Publications
History of USPTO decisions and trademark events.
34 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/26/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/07/2024
FIMP
FINAL DISPOSITION PROCESSED
11/07/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/14/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/27/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/26/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/11/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/11/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/11/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2024
RFNT
REFUSAL PROCESSED BY IB
10/17/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2023
RFRR
REFUSAL PROCESSED BY MPU
09/25/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/07/2023
CNRT
NON-FINAL ACTION WRITTEN
09/06/2023
DOCK
ASSIGNED TO EXAMINER
09/06/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/13/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/06/2023
Continuous trademark protection
Get notified about every new filing that threatens EXSCALATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.